デジタル治療の世界市場(~2028年):製品タイプ別(デバイス、ソフトウェア)、用途別(予防用、治療/ケア用)、地域別

■ 英語タイトル:Digital Therapeutics Market Forecasts to 2028 – Global Analysis By Product Type (Device, Software), Application (Preventive Applications, Treatment/Care-related Applications) and By Geography

調査会社Stratistics MRC社が発行したリサーチレポート(データ管理コード:SMRC21DC182)■ 発行会社/調査会社:Stratistics MRC
■ 商品コード:SMRC21DC182
■ 発行日:2021年9月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:n/a
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥614,200見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
EnterprisewideUSD7,500 ⇒換算¥1,110,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[デジタル治療の世界市場(~2028年):製品タイプ別(デバイス、ソフトウェア)、用途別(予防用、治療/ケア用)、地域別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

本調査レポートでは、デジタル治療の世界市場を広く調査し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品タイプ別(デバイス、ソフトウェア)分析、販売チャネル別(B2C、B2B)分析、用途別(予防用、治療/ケア用)分析、地域別分析、主要市場開拓、企業情報などの項目を掲載しています。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・デジタル治療の世界市場規模:製品タイプ別(デバイス、ソフトウェア)
・デジタル治療の世界市場規模:販売チャネル別(B2C、B2B)
・デジタル治療の世界市場規模:用途別(予防用、治療/ケア用)
・デジタル治療の世界市場規模:地域別
・主要市場開拓
・企業情報

According to Stratistics MRC, the Global Digital Therapeutics Market is accounted for $3.50 billion in 2020 and is expected to reach $16.62 billion by 2028 growing at a CAGR of 21.5% during the forecast period. Significant increase in venture capital investments, growing focus on preventive healthcare, rising incidence of preventable chronic diseases are the major factors propelling the market growth. However, patient data privacy concerns, resistance from traditional healthcare providers, and reluctance among patients to adopt digital therapeutics are hampering the market growth.

Digital therapeutics provides evidence-based treatment with software that replaces or complements existing treatment for a disease. It is a subdivision of digital health, and not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on the clinical outcomes of the patient. For instance, digital therapeutics does not include consumer health-oriented technologies such as pedometers and calorie counters. It is new types of healthcare products that uses digital technology to prevent, control, or treat medical conditions.

Based on product type, the software segment is estimated to have a lucrative growth due to the rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use existing software and develop new and advanced features to make them more effective and affordable. Thus, this factor is anticipated to help in increasing the digital therapeutics market size in the near future.

By geography, North America is going to have a lucrative growth during the forecast period due to the increase in geriatric population, rise in incidences of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure. Furthermore, the U.S. FDA released guidelines to expand the availability of digital health therapeutic devices for psychiatric conditions. Owing to this, the FDA intended to support individuals that were following home quarantine orders or practicing social distancing, without the need for in-clinic visits during the COVID-19 public health emergency. This would also ease burdens on healthcare facilities and reduce the risk of exposure to the virus.

Some of the key players profiled in the Digital Therapeutics Market include 2Morrow, Inc., Akili Interactive Labs, Inc, Canary Health, Inc., Click Therapeutics, Inc, Happify, Inc, Kaia Health, Livongo Health, Inc, Mango Health, Inc., Medtronic Plc, Noom Health, Inc., Omada Health, Inc, Pear Therapeutics, Inc, Propeller Health, Proteus Digital Health, Inc, Twine Health, Inc., Voluntis, Inc, and Welldoc, Inc.

Product Types Covered:
• Device
• Software

Sales Channels Covered:
• Business-to-Consumer (B2C)
• Business-to-Business (B2B)

Applications Covered:
• Preventive Applications
• Treatment/Care-related Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

*** レポート目次(コンテンツ)***

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Digital Therapeutics Market, By Product Type
5.1 Introduction
5.2 Device
5.3 Software

6 Global Digital Therapeutics Market, By Sales Channel
6.1 Introduction
6.2 Business-to-Consumer (B2C)
6.2.1 Caregivers
6.2.2 Patients
6.3 Business-to-Business (B2B)
6.3.1 Employers
6.3.2 Healthcare Provider
6.3.3 Payers
6.3.4 Pharmaceutical Companies

7 Global Digital Therapeutics Market, By Application
7.1 Introduction
7.2 Preventive Applications
7.2.1 Lifestyle Management
7.2.2 Nutrition
7.2.3 Obesity
7.2.4 Prediabetes
7.3 Treatment/Care-related Applications
7.3.1 Cardiovascular Disease (CVD)
7.3.2 Central Nervous System (CNS) Disorders (Mental Health Disorder)
7.3.3 Chronic Respiratory Disorders
7.3.4 Diabetes
7.3.5 Gastrointestinal Disorder (GID)
7.3.6 Medication Adherence
7.3.7 Musculoskeletal Disorders
7.3.8 Rehabilitation & Patient Care
7.3.9 Smoking Cessation
7.3.10 Substance Use & Addiction Management

8 Global Digital Therapeutics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 2Morrow, Inc.
10.2 Akili Interactive Labs, Inc
10.3 Canary Health, Inc.
10.4 Click Therapeutics, Inc
10.5 Happify, Inc
10.6 Kaia Health
10.7 Livongo Health, Inc
10.8 Mango Health, Inc.
10.9 Medtronic Plc
10.10 Noom Health, Inc.
10.11 Omada Health, Inc
10.12 Pear Therapeutics, Inc
10.13 Propeller Health
10.14 Proteus Digital Health, Inc
10.15 Twine Health, Inc.
10.16 Voluntis, Inc
10.17 Welldoc, Inc



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(SMRC21DC182 )"デジタル治療の世界市場(~2028年):製品タイプ別(デバイス、ソフトウェア)、用途別(予防用、治療/ケア用)、地域別" (英文:Digital Therapeutics Market Forecasts to 2028 – Global Analysis By Product Type (Device, Software), Application (Preventive Applications, Treatment/Care-related Applications) and By Geography)はStratistics MRC社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。